BamSEC and AlphaSense Join Forces
Learn More

SAB Biotherapeutics Inc. – Transcripts

NASDAQ: SABS    
Share price (11/6/26): $3.03    
Market cap (11/6/26): $273 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Earnings Revised 11/06/26 SAB Biotherapeutics, Inc., Q3 2026 Earnings Call, Nov 05, 2026 11/05/26
Other Revised 09/10/26 SAB Biotherapeutics, Inc. Presents at Citigroup’s Biopharma Back to School Summit 2026, Sep-10-2026 11:20 AM 09/10/26
Earnings Revised 08/18/26 SAB Biotherapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 08/06/26
Earnings Revised 07/08/26 SAB Biotherapeutics, Inc., Q1 2026 Earnings Call, May 12, 2026 05/12/26